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More than 30,000 types of plants and 1,000 types of 
medicinal plants have been used in the traditional 
medicinal industry in Indonesia. Medicinal plants 
are, in general, forest plants that have been grown in 
yards and hereditarily used as traditional medicine 
since the era of ancestors. Recently, they have been 
widely developed as Indonesian traditional herbal 
medicine, namely “jamu”, standardised herbal 
medicine, and phytopharmacy (Anam et al., 2013). 
“Bawang Dayak” (Eleutherine bulbosa Urb.) is an 
example of medicinal plants, nutritious for health 
but still scarcely used in community medicine. This 
plant is commonly found in South Kalimantan island, 
where the locals already use it as traditional 
medicine. Its bulbs are widely used for several 
therapeutic purposes. E. bulbosa Urb. effectively 
reduces cholesterol (Anjar, 2016) and has 
antihypertensive, immunomodulatory, and anti-
inflammatory activities (Muthia & Astuti, 2018; 
Paramita & Nuryanto, 2018; Rauf et al., 2018). The 
bulb extracts contain flavonoids, phenolics, 
saponins, and tannins (Andi et al., 2013; Pratiwi et 
al., 2013; Muthia et al., 2021).  
Acute toxicity testing is a preclinical test aiming to 
measure the toxic effects (degree of toxicity) of a 
compound or chemical that occurs immediately or 
shortly after it is delivered orally as a single dose or 
repeatedly within 24 hours (WHO, 2004). It is 
designed to quantitatively measure the Lethal Dose 
50 (LD50) of a substance. Its parameter includes the 
mortality of the test animals (Dipasqual, 2001). 
Medicinal plants must go through various testing 
processes for the safety of their consumption, one of 
which is the acute toxicity test (Syamsul et al., 2015). 
As E. bulbosa Urb has many therapeutic and non-


















Introduction: Eleutherine bulbosa Urb is a plant species with medicinal properties, 
including anti-inflammatory, widely relied upon in traditional practices. For this reason, 
the present research was intended to assess and, thus, ensure the safety of this plant 
for conventional medicinal purposes using a toxicity test study.    Methods: The acute 
toxicity test of the ethanolic extract of E. bulbosa Urb (EEEB) used the method adopted 
from the Organization Economic Cooperation and Development (OECD) guidelines 
425 for testing Wistar rats.    Results: During 14 days of the acute toxicity study, there 
were no significant changes in rat weight, no mortality, and no signs of toxicity after 
the oral EEEB administration at 2000 mg/kg body weight (bw). The limit test showed 
that the LD50 of EEEB was higher than 2000 mg/kg bw.    Conclusion: EEEB has low 
toxicity because its LD50 is higher than the limit test results. 
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Plant collection and sample preparation 
The Eleutherine bulbosa Urb plants were collected from 
Banjarbaru, South Kalimantan, and determined at the 
Herbarium Bogoriense, Biology Research Center, 
Indonesian Institute of Sciences (LIPI) Bogor, with the 
registration number 2244/IPH.1.01/If.07/XII/2019. The 
bulbs were separated, cleaned, washed, cut into small 
pieces, and dried by aeration. Afterwards, the dried 
bulb samples were ground to fine powders, which were 
later sieved using mesh number 16 and stored in closed 
containers. 
 
Bulb extract preparation 
The bulb powders obtained from the previous 
procedure were extracted by maceration for 24 hours, 
using 96% ethanol as the solvent (DepKes, 2014). The 
resulting filtrate was filtered, and the residual pulp was 
macerated twice using the same maceration procedure 
and solvent. The ethanolic extract was evaporated in a 
rotary evaporator at 45oC and a water bath until a fixed 
weight was reached. 
 
Approval from the animal ethics committee 
The acute toxicity test was performed on seven healthy 
non-pregnant female Wistar rats aged 2-3 months old 
and weighing about 100-200 grams. The procedures 
involved were conducted after receiving approval from 
the institutional ethical committee University of 
Surabaya No: 141/KE/X/2020. 
 
Acute toxicity test 
As per the OECD Guidelines 425 (Up-and-Down 
Procedure) (OECD, 2001; OECD 2008), the test rats 
were kept in a standard condition for 15 days. The limit 
test for single peroral administration was conducted at 
2000 mg/kg body weight (bw). The test rats were given 
no food three to four hours before the administration 
but had ad libitum access to water. After the prepared 
extract was given to one female rat, it was closely 
observed for any toxic effects in the first 30 minutes, 4 
hours, and then regularly (at an interval of 24 hours) for 
14 days. Food was provided one to two hours after the 
administration. If this test rat survived the procedure, 
the extract was given to four additional rats at the same 
dose and under the same conditions. These five test 
rats were labelled as the treated group. However, if it 
died, the main test to calculate the LD50 of responses 
was initiated. If three animals died, the limit test was 
terminated, then the main test was performed. The 
LD50 was greater than 2000 mg/kg bw if three or more 
test animals survived the procedure. Apart from the 
treated group, the experiment also used two other test 
rats as the control (vehicle-treated group). This group 
was given 1% carboxymethyl cellulose (CMC) gel orally, 
then, like the treated group, monitored for any toxic 
effects in the first 30 minutes, four hours, and at a 
regular interval of 24 hours for 14 days. The test rats 
that survived were examined for the onset of toxic 
reactions; their weights were also monitored and 
documented until the end of the study (OECD 2001; 
OECD 2008). The LD50 was computed in the Acute Oral 
Toxicity (AOT) 425 StatPgm software.  After the 
experiment, the test rats that survived were 
anesthetised and sacrificed for histopathology.   
 
Statistical analysis 
The body weights were expressed as mean±SD, and the 
statistical significance between the treated and control 
groups was analysed using an independent-samples t-




Behavioural pattern and body weight 
Table I shows the test rats’ weights in the control and 
treated groups. Table II presents the behavioural 
pattern of these rats observed after administering the 
ethanolic extract of E. bulbosa Urb. 
 
Table I: Mean weight of the test rats in control and 
treated groups in the 14-day acute toxicity test 
Treatment Body weights (g)  
Day 0 Day 1   Day 7 Day 14 
Control 154.7±27.08 155.5±23.3 173.5±6.3 189.5±2.1 
EEEB 153.8±17.7 147.8±15.6 169.8±12.6 173.6±17.8 
Value provided as mean±SD (n=2) for control; (n=5) for treated group 
 
Table II: Toxicity symptoms in control and treated 
groups in the acute toxicity test 
Parameters  Symptoms of Toxicity 
30 minutes 4 hours 24 hours 14 days 
CG TG CG TG CG TG CG TG 
Fur & Skin  N N N N N N N N 
Eyes  N N N N N N N N 
Respiration  N N N N N N N N 
Convulsions  NF NF NF NF NF NF NF NF 
Tremors  NF NF NF NF NF NF NF NF 
Diarrhea  NF NF NF NF NF NF NF NF 
Mortality  NF NF NF NF NF NF NF NF 
CG = Control Group; TG = Treated Group; N = Normal; NF = Not Found 
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Acute toxicity test results 
All rats used in the toxicity test of the ethanolic extract 
of Eleutherine bulbosa Urb., which were administered 
at 2000 mg/kg bw, showed no symptoms of toxicity 
and survived until Day 14 of the observation, meaning 
that the LD50 of this extract is higher than 2000 mg/kg 
bw. At this state, the LD50 fell into category 5: no 
symptoms of toxicity at a dose of 2000 mg/kg bw. 
Screenshots of the acute toxicity test results in the 
AOT 425 StatPgm software are presented in Figure 1. 
 
Histopathological results 
Treated rats were given the ethanolic extract of 
Eleutherine bulbosa Urb at a limit dose of 2000mg/kg bw. 








Figure 2: Liver and heart histopathological sections of the control and treated rats  
(Hematoxylin and Eosin staining, 40x10 magnification) 
Liver of control/untreated rats 
 
Liver of treated rats 
 
Heart of control/untreated rats 
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All test rats survived the toxicity study of the ethanolic 
extract of Eleutherine bulbosa Urb at a dose of 2000 
mg/kg bw. The observations were made in the first 30 
minutes up to 4 hours after the extract administration 
and then periodically for 14 days, meaning that the 
resulting LD50 of the ethanolic extract was from a dose 
higher than 2000 mg/kg bw.  
As seen in Tables I and II, the control group gained 
weight throughout the 14 days of the toxicity study, 
while the treated group experienced fluctuating 
weights until the end of the observation. Weight 
changes are considered the manifestation of the toxic 
effects of a substance (Jothy et al., 2011; BPOM 2014). 
Generally, the decrease in the weight of the body and 
internal organs are simple and sensitive indices of 
toxicity after exposure to toxic substances. Changes in 
body weight are indicators of drug and chemical 
adverse effects, considered significant if the loss is 10% 
from initial body weight (Vaghasiya et al., 2011). The 
average body weight was analyzed using the statistical 
independent-samples t-test on SPSS, and no significant 
differences in body weight were found between the 
control group and the treatment group. The 
independent t-test of these weights resulted in a sig (2-
tailed) value of 0.533, with p > 0.05. Wati et al. (2018) 
confirm no body weight change in the acute toxicity 
test, suggesting normal body metabolic processes 
(Klaassen, 2018). The acute toxicity of the ethanolic 
extract of Eleutherine bulbosa Urb was assessed in mice 
after orally administered at 1000, 2000, 3000, 4000, 
and 5000 mg/kg BW. These doses neither caused 
mortality nor show signs of toxicity (Hanh et al., 2018). 
In the OECD 425 guidelines (2008), toxicity can be 
reflected by changes in skin, hair, and eyes. Other signs 
include lethargy, convulsions (seizures), tremors, 
diarrhoea, and death of the test animals. In this study, 
the test rats were examined for any of these toxicity 
symptoms. During 14 days of observation, no such 
manifestations were found in the test rats. Also, the 
administration of the ethanolic extract of E. 
bulbosa Urb bulbs at 2000 mg/kg bw did not cause 
mortality. The LD50 of this extract was found to be 
higher than 2000 mg/kg bw, which, according to the 
criteria for preparations set by BPOM RI (2014), is 
classified as "mildly toxic". For this reason, it is safe to 
suggest that relevant national or state agencies for 
food and drug controls, especially the ones in 
Indonesia, can authorise the mass production of 
preparations made of this ethanolic extract.  
The histopathological sections presented in Figure 2 
show that the treated rat’s liver exhibited hydropic 
degeneration and no hepatocyte necrosis. Liver fatty 
degeneration is damage to hepatocytes marked by 
morphological changes and decreased organ function 
due to fat accumulation in the cytoplasm of liver cells, 
as apparent from the clear microscopic patches of fat. 
Similarly, the heart of the rats treated with the 
ethanolic extract at a limit dose of 2000mg/kg bw 
showed normal myocytes (Aiyalu & Ramasamy, 2016). 
 
Conclusion  
The LD50 of the ethanolic extract of Eleutherine bulbosa 
Urb is higher than 2000mg/kg bw, and no toxicity 
symptoms have been found.  
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